Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support
Clinical trial NCT00506857 · COMPLETED
Trial details
- NCT number
- NCT00506857
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2011-08-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.